133 related articles for article (PubMed ID: 10572381)
1. Alternative pathway of complement is activated during in vitro ventricular assist.
Chen JC; Huynh TN; Serna DL; Sun CP; Ha H; Steward E; Webster S; Brenner M
J Investig Med; 1999 Nov; 47(9):502-6. PubMed ID: 10572381
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
3. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist.
Serna DL; King BO; Huh J; Jalal R; Tran L; Chen JC
J Investig Med; 1998 Aug; 46(6):279-83. PubMed ID: 9737089
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
[TBL] [Abstract][Full Text] [Related]
5. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
6. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
8. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
Kirschfink M; Kovacs B; Mottaghy K
Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in diabetic ketoacidosis and its treatment.
Jerath RS; Burek CL; Hoffman WH; Passmore GG
Clin Immunol; 2005 Jul; 116(1):11-7. PubMed ID: 15925827
[TBL] [Abstract][Full Text] [Related]
11. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
Sundsmo JS; Wood LM
J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
[TBL] [Abstract][Full Text] [Related]
12. Screening biomaterials for functional complement activation in serum.
Lyle DB; Bushar GS; Langone JJ
J Biomed Mater Res A; 2010 Jan; 92(1):205-13. PubMed ID: 19172622
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
14. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
Aguado MT; Celada A
Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
[TBL] [Abstract][Full Text] [Related]
15. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
Kozlov LV; Zinchenko AA; Soliakov LS; Sizoĭ MN; Ishchenko AM
Bioorg Khim; 1983 Aug; 9(8):1047-55. PubMed ID: 6680304
[TBL] [Abstract][Full Text] [Related]
16. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
17. Classical pathway complement activation in Kawasaki syndrome.
Kohsaka T; Abe J; Asahina T; Kobayashi N
J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
[TBL] [Abstract][Full Text] [Related]
18. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
Takematsu H; Tagami H
Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
[TBL] [Abstract][Full Text] [Related]
19. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
20. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
Buyon JP; Tamerius J; Belmont HM; Abramson SB
Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
